Alkermes

Orexin's discoverers win the Lasker basic-science award a month after the first agonist approval

Emmanuel Mignot and Masashi Yanagisawa reached the same wakefulness peptide from opposite directions. The drug class that followed now holds one narcolepsy approval and a much larger set of untested hopes.